SeQure Dx, Inc.
- Home
- Companies
- SeQure Dx, Inc.
- Products
- SeQureDx - Personalized Diagnostics for ...
SeQureDx - Personalized Diagnostics for Gene Editing Therapies
FromSeQure Dx, Inc.
GUIDE-seq and ONE-seq are used to nominate potential off-target editing sites in cellular models and free DNA, respectively. ONE-seq has the advantages that it can be used to assess adenine and cytosine base editors, it allows variant-aware analysis of multiple genomes simultaneously (thousands), and it detects a broader spectrum of off-target sites. Target cells or tissues are then tested to confirm which of the nominated sites are altered after therapeutic gene editing.